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A B S T R A C T -------------------------------------------------
OBJECTIVE: To create an affordable and accurate meth­
od for continuously monitoring bacterial transmission rates in 
healthcare settings.
DESIGN: We present a discrete simulation model that re­
lies on the relationship between in-hospital transmission rates 
and strain diversity. We also present a proof of concept applica­
tion of this model to a prospective molecular epidemiology data 
set to estimate transmission rates for Pseudomonas aeruginosa 
and Staphylococcus aureus.
SETTING: Inpatient units of an academic referral center. 
PATIENTS: All inpatients with nosocomial infections.
INTERVENTION: Mathematical model to estimate trans­
mission rates.
RESULTS: Maximum likelihood estimates for transmis­
sion rates of these two species on different hospital units ranged 
from 0 to 0.36 transmission event per colonized patient per day.
CONCLUSIONS: This approach is feasible, although es­
timates of transmission rates based solely on strain typed clini­
cal cultures may be too imprecise for routine use in infection 
control. A modest level of surveillance sampling substantially 
improves the estimation accuracy (Infect Control IIosp Epidemiol 
2005;26:638-645).
Infection control interventions aim to reduce the 
rate of transmission of infectious agents between patients. 
Unfortunately, success in achieving this goal is difficult 
to measure directly as conventional metrics such as the 
nosocomial infection rate are affected by several factors in 
addition to the transmission rate. Strain typing of bacterial 
isolates recovered from clinically directed or surveillance 
cultures provides additional information.1'2 Typing is most 
commonly performed as part of an outbreak investigation, 
but it has also proved useful in identifying transmission 
in the absence of clinically apparent epidemics.3 In both 
circumstances, strain typing data are typically interpreted 
qualitatively. The question usually posed is does a particu­
lar set of colonized or infected patients represent a cluster 
related to cross-infection or a common source?
Another approach to quantifying transmission rates 
involves use of serial surveillance cultures.4'5 B y detecting 
colonized but uninfected individuals and ascertaining the 
time interval of acquisition, this approach captures much 
more information about transmission. However, this strat­
egy is impractical for routine use in most hospital settings, 
due primarily to the cost of obtaining and processing large 
numbers of cultures.
It would be desirable to have a method for estimating 
transmission rates based on more affordable data sets and
that takes full advantage of the information available from 
strain typing. Rapid developments in automated molecular 
techniques make it practical to perform strain typing on all 
clinical bacterial isolates grown in a hospital laboratory. Our 
goal was to infer transmission rates based on these types of 
data, fitting an explicit transmission model for purposes of 
parameter estimation.
This article describes an application of this method 
to a study in which isolates from nosocomial infections at 
an academic medical center were routinely strain typed 
during a period of 8 months. With reliance on the simplify­
ing assumptions of the model, Monte Carlo simulation was 
used to produce a test statistic across a range of possible 
parameter values. The Monte Carlo-generated test statistic 
was then compared with the actual test statistic to derive a 
maximum likelihood estimate of the transmission param­
eter. The benefits and drawbacks of this technique are de­
scribed, along with suggestions for future work.
M E T H O D S
P a tie n t P o p u la tio n  a n d  M olecular Typing D a ta
A prospective study was conducted from January to 
August 2000 at a 400-bed, tertiary-care medical center. The 
study population consisted of all patients for whom a gram- 
negative rod. Staphylococcus aureus, or both were recovered
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TABLE 1
HOSPITAL WARDS, NUMBERS OF
Period


















Burn ICU 23 (13) 24 (16) 64 9.7 7.6
Surgical ICU 14 (10) 16(8) 55 10.5 4.0
Medical/surgical A 7(6) 9(9) 46 31.9 3.9
Neurology ICU KD 15 (10) 36 9.2 3.2
Physical medicine/rehabilitation 4(3) 5(4) 33 17.7 12.4
Medical/ surgical B 6(5) 8(7) 32 26.4 3.4
Medical/ surgical C 3 (3) 12(8) 27 17.3 4.4
Newborn ICU KD 10 (7) 25 31.3 26.0
Medical ICU 5 (5) 9(7) 24 8.7 3.6
Neurology 3 (3) 6(3) 23 22.1 3.3
ICU = intensive care unit.
from a clinical culture performed at least 2 days after hospi­
tal admission. In the case of multiple cultures from a single 
patient, only the first isolate of the infecting species was 
used for this modeling study. These strains were character­
ized by ribotyping using the RiboPrinter Microbial Charac­
terization System (DuPont Qualicon, Wilmington, DE) with 
Pvull as the restriction enzyme for Pseudomonas and £coRI 
as the restriction enzyme for all other bacteria. Isolates 
were classified into ribogroups on the basis of banding pat­
tern concordance, as determined by the computer software 
accompanying the RiboPrinter System. Overall, 391 isolates 
were ribotyped from 19 different hospital wards. These fell 
into 229 unique ribogroups. Approximately three-quarters 
of the isolates were from just three species: Staphylococcus 
aureus (120 isolates), Escherichia coli (85 isolates), and 
Pseudomonas aeruginosa (73 isolates).
Strain typing data were segregated into groups by 
species and hospital unit to apply the transmission model. 
Because the information content of the data is directly relat­
ed to the number of data points, only data from the 10 wards 
with the largest numbers of clinical cultures were analyzed 
further. The data were further narrowed to S. aureus and 
P. aeruginosa. These species were chosen because of the 
relatively large numbers of data points for them and be­
cause, in contrast to E. coli, these are species with which 
patients may be less likely to simultaneously harbor mul­
tiple strains,6'7 which satisfies one of the key assumptions 
of the transmission model. The number of S. aureus clinical 
cultures during the study period per each of the 10 units 
studied ranged from 5 to 24; the number of P. aeruginosa 
clinical cultures ranged from 1 to 23 (Table 1).
All patient-derived data were de-identified prior to 
use in this modeling study. The study design was reviewed 
by the University of Utah Institutional Review Board and 
determined to be exempt from federal regulation govern­
ing human research.
Model D escription
Overview. A  stochastic, discrete-time transmission 
model was constructed to simulate a closed hospital en­
vironment in which patients are admitted and discharged 
and share bacteria with each other (Appendix). Within the 
model, individual patients are traced so that the frequency 
distribution of specific strains can be followed. The param­
eters in the model include the number of unique strains 
in the community, the admission rate, the number of 
beds on the unit, the probability of colonization at admis­
sion, and the transmission rate (ie, the average number 
of transmission events per colonized patient per day). In 
addition to these parameters, the model incorporates the 
observed number and timing of clinical cultures. In this 
model, “colonized” refers to all patients harboring a strain 
of bacteria, and thus includes infected patients as well.
It is assumed that a large number of distinguish­
able strains of this species are present in the surrounding 
community. On admission, each patient who is colonized 
harbors a randomly selected strain. Bacterial strains are 
transmitted between patients on a hospital ward at a rate 
proportionate to the number of colonized patients. All pa­
tients are considered susceptible to acquisition of a new 
strain. Previously non-colonized patients who are the re­
cipients of a transmission event become colonized with the 
strain of the transmitter. For previously colonized patients, 
a transmission event results in strain replacement with a 
new strain. It is assumed that colonized patients do not re­
vert to the non-colonized state during their hospital stay. In 
this way, each patient harbors exactly zero strains or one 
strain of the species at any given point in time. Discharge 
is assumed to occur concurrently with admission (ie, dis­
charge results in replacement of an individual with another 
patient from the community).
Cultures occur at specified points in time and allow 
the strain colonizing the patient to be observed. A  culture
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TABLE 2








Probability of colonization at admission 0.05-0.5 0.15-0.6 0.71-0.72 5.06-8.21
Census, no. of patients 5-15 0.20-0.55 0.71-0.71 7.28-7.29
Average lengtli of stay, d 4-12 0.15-0.97 0.59-0.86 5.64-8.1
Window size on statistic, d 10-285 0.16-0.28
No. of community strains 10-100.000 0.16-0.26 0.68-0.71 7.27-7.29
'Transmissions per cduni/x-d patient per day.
is modeled by randomly selecting a colonized patient (as 
the data set includes only positive cultures) and recording 
the strain harbored by that patient at that point in time. The 
model assumes that each patient is cultured at most once 
during the hospital stay.
Sim ulations. The behavior of the model was ex­
plored by simulation. Strain diversity and colonization prev­
alence were assessed at the end of each simulation. Strain 
diversity was measured using Simpson’s index of diversity,8 
which is the probability of finding two different strains on 
choosing twice, with replacement, from a set of colonizing 
isolates. Colonization prevalence was the proportion of 
patients in the simulation who were colonized at that time.
A base-case model was developed, using parameter 
values derived from the following sources. The per-bed ad­
mission rate, which equaled the discharge rate, was set to 
the reciprocal of the observed average length of stay for each 
unit. The number of patients was set to the average census of 
each unit, rounded to the nearest integer. The number and 
timing of clinical cultures was taken directly from observed 
hospital infection data. The probability of colonization at ad­
mission was estimated from the literature for a particular 
species. In our study, the baseline estimate of the probability 
of colonization at admission was set to 0.2 for S. aureus? and
0.3 for P. aeruginosa.10 The number of unique strains in the 
community was set to an arbitrary large number (1,000 in the 
simulation experiments reported here) so that the probability 
of two patients being independently admitted with the same 
strain was much lower than the probability of two patients 
sharing a strain due to a transmission event. In principle, this 
parameter could be set to a number reflective of the discrimi­
natory power of the strain typing method being used.
The model was programmed in Java (Sun Microsys­
tems, Santa Clara, CA) and all simulations were run on a 
personal computer with a Pentium-Ill processor (Intel, 
Santa Clara, CA). As part of validating the program, a spe­
cial case of the model was solved analytically using Markov 
chain theory.11 The theoretic steady-state values predicted 
by the Markov chain were compared with results generated 
via Monte Carlo simulation.
F ittin g  the Model to the D a ta
S ta tistica l Approach. Monte Carlo integration 
was used to determine maximum likelihood estimates for
the target parameter (the transmission rate), as the com­
plexity of the model made direct calculation of likelihoods 
impractical. A  range of transmission rates was entered into 
the model, setting other parameters to values used in the 
base-case model. For each rate, a large number of simula­
tions were performed, and the results were summarized by 
means of a test statistic. If this matched the test statistic 
observed in the original data set, the simulation was ac­
cepted; otherwise it was rejected.1215 The likelihood profile 
was then obtained by plotting the acceptance rate against 
the transmission rate.
Test S tatistic. A  test statistic was devised to reflect 
the relative proportion of observed isolates with recent 
same-strain matches. More specifically, given a species 
and hospital ward, it equals the number of clinical isolates 
that match the strain of at least one previous isolate from a 
different patient on that ward within a fixed time window, 
divided by the total number of isolates for which at least 
one previous isolate was observed within that time window. 
The use of this test statistic assumed that cultures were not 
performed in response to a suspected cluster. Examples of 
valid data sets for this type of test statistic would include 
strain typing of all clinical isolates, random surveillance cul­
tures, or both.
The rationale for this statistic is that in the absence of 
transmission between patients, bacteria within the hospital 
would be expected to show the same level of strain diver­
sity as bacteria in the community. As the transmission rate 
increases, diversity would be expected to decrease, thus 
increasing the probability that two randomly selected iso­
lates would be the same strain. As with the model itself, the 
test statistic presented here should be thought of as a proof 
of concept, rather than as an exhaustively studied optimal 
solution.
For the experiments reported here, the time window 
on the test statistic was fixed at 14 days; this choice was 
somewhat arbitrary and represents an empirically guided 
compromise. On one hand, the smaller the number of days 
between same-strain infections, the stronger the evidence 
for a high transmission rate. For this reason, decreasing 
the size of the window up to a certain point decreases the 
width of the confidence interval around the maximum like­
lihood estimate. On the other hand, as the window size is 
narrowed beyond a certain point, the decrease in the num­
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ber of same-species infections begins to increase the width 
of the confidence interval. For most of the ward-species 
pairs studied here, the width of the confidence interval was 
minimized at approximately 14 days, and so this was fixed 
as the window size for all subsequent experiments.
Monte C arlo  In te g ra tio n . Each simulation in­
cluded a 100-day run-in period to reach steady-state prob­
abilities for strain sharing among patients. Steady-state 
strain diversity and colonization prevalence are achieved 
by approximately day 25, and so the use of 100 days was 
conservative. This was followed by an 8-month period 
during which sampling occurred. For each simulation, 
it was recorded whether the number of same-strain in­
fections within 14 days of each other matched the cor­
responding number from the ribotyping data set. The 
proportion of simulations with matching results was 
then plotted against the transmission rate, yielding the 
likelihood profile. The peak of this curve represents the 
maximum likelihood estimate for the transmission rate, 
and the curvature is related to the precision of the es­
timate. Ninety-five percent confidence intervals were 
approximated from support intervals according to the 
method of Hudson16 as the range of transmission rates 
for which the natural log of the likelihood was within 2.0 
of the maximum log-likelihood.
For each species-ward pair, the model was initially 
run for 10,000 simulations per transmission rate, varying 
the transmission rate over a logarithmic scale. The result­
ing likelihood curves were all unimodal with unambiguous 
peaks. The locations of the peaks and the limits of the con­
fidence intervals were then determined more precisely by 
rerunning the model at 50,000 simulations per transmission 
rate and varying the transmission rate linearly over regions 
around the peak, lower confidence limit, and upper confi­
dence limit predicted by the initial runs. Because the log- 
likelihood curves were approximately linear in the regions 
around the confidence interval limits, the values for these 
limits were determined by linear interpolation.
Sensitivity A nalysis
For sensitivity analysis, the burn intensive care unit 
P. aeruginosa parameters were used as a baseline. Each of 
the input parameters, as well as the length of the run-in pe­
riod, were varied across a biologically plausible range for 
the burn intensive care unit. The effects of these changes 
on the maximum likelihood estimates, on mean strain diver­
sity, and on mean colonization prevalence are presented in 
Table 2. The maximum likelihood estimates were derived 
using the method described above; the Simpson’s index of 
diversity and mean colonization prevalence were studied 
separately by running 10,000 simulations for each set of 
parameters.
To investigate the benefit of increasing the amount 
of information available to the model, the effect of per­
forming weekly surveillance cultures on the confidence 
limits of the estimate of the transmission rate was as­
sessed. Non-infected patients in the model were randomly 
selected at specified times and strains were recorded. A
o --------------- - --------------
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transmission rate
FIGURE 1. Predicted colonization prevalence and strain diversity versus 
transmission rate.
maximum of one culture was assumed per patient per hos­
pital stay, regardless of whether it was a clinical culture 
or a surveillance culture. The surveillance culture simula­
tions used the parameters and P. aeruginosa infection data 
from the burn intensive care unit, with the test statistic 
fixed at values that would give the same maximum like­
lihood estimates for the transmission rate as the unaug­
mented burn intensive care unit data. The model was then 
applied to the augmented burn intensive care unit data, 
including clinical plus simulated surveillance cultures, to 
determine the confidence intervals around the maximum 
likelihood estimates.
RESULTS
C h aracteristics  o f the Model
With the use of the burn intensive care unit P. 
aeruginosa parameters as a baseline, the model predic­
tions for colonization prevalence and strain diversity were 
studied by calculating these values at the end of each of a 
large number of simulations. The mean colonization prev­
alence predicted by the model was 72.7%, with 2.5th and 
97.5th percentile values of 40% and 100%, respectively. The 
mean Simpson’s index of diversity was 0.46, with 2.5th and 
97.5th percentile values of 0.00 and 0.78, respectively. The 
effects of varying the transmission rate on mean coloniza­
tion prevalence and mean Simpson’s index are shown in 
Figure 1.
A pplication to H ospital D a ta  Set
Across the hospital wards studied, the estimated 
transmission rate for S. aureus ranged from 0.0 to 0.36 
transmission per colonized patient per day, and the es­
timated rate for P. aeruginosa ranged from 0.13 to 0.28 
(Table 3). There was substantial overlap among the 
95% confidence intervals. For several of the ward-spe­
cies subsets, there were no same-strain clinical cultures 
within 14 days of each other, and so the maximum likeli­
hood estimate for the transmission rate was 0. For wards
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TABLE 3




















Burn ICU Pseudomonas aeruginosa 17 7 0.076 0.26 (0.09-1.19)
Staphylococcus aureus 18 3 0.079 0.07 (0.01-0.14)
Surgical ICU P. aeruginosa 9 1 0.021 0.13 (0.005-0.69)
S. aureus 11 4 0.024 0.36 (0.11-2.1)
Medical/surgical A S. aureus 3 0 0.0046 0.0 (0.0-2.58)
Neurology ICU S. aureus 9 1 0.021 0.13 (0.006-0.58)
Medical/surgical B S. aureus 3 0 0.0038 0.0 (0.0-4.21)
Medical/surgical C S. aureus 5 1 0.012 0.18 (0.01-2.19)
Newborn ICU S. aureus 4 0 0.035 0.0 (0.0-0.18)
ICU = intensive care u n it CI95 = 95% confidence interval. 
* Infections per patient-day.
^Transmissions per colonized patient per day.
and spccics with only a few clinical cultures, the confi­
dence intervals were so wide as to render the maximum 
likelihood estimate of the transmission rate essentially 
meaningless. Thus, the only results reported here are 
those from ward-species subsets with confidence inter­
val widths of less than 5 transmissions per colonized pa­
tient per day.
The widths of the confidence intervals are directly 
related to the numbers of cultures for each species-ward 
subset. This is shown most clearly when the simulated 
surveillance cultures are added to the clinical cultures. In 
Figure 2, the confidence intervals around the transmission 
rate estimate are plotted against the total number of cul­
tures performed. Given this transmission model and the 
observed data, it appears that adding a modest number of 
random surveillance cultures (equal to one or two times the 
number of clinical cultures) would markedly narrow the 
width of the confidence interval. On the other hand, adding 
further surveillance cultures beyond that number would be 
of limited benefit.
The sensitivity analysis (Table 2) showed maximum 
likelihood estimates to be most sensitive to the length of 
stay, probability of colonization at admission, and cen­
sus. Of these parameters, length of stay and census can 
be directly observed in practice, significantly reducing 
their potential to introduce error into the final estimate. 
Maximum likelihood estimates were fairly stable regard­
ing the number of community strains and the size of the 
time window.
D IS C U S S IO N
This study addressed the need for an efficient 
method to quantitatively monitor transmission rates in 
healthcare settings. We have described a new dynamic 
transmission model that incorporates strain typing data 
and allows both non-colonized and colonized patients to
acquire new organisms from other colonized patients. 
Calculations on the model are performed by Monte 
Carlo integration. Several simplifying assumptions are 
imposed, but the fallacy of conventional statistical meth­
ods that assume infectious events in individuals are in­
dependent is avoided. The model is presented as a proof 
of concept; further work would be required to create an 
application to meet the needs of a hospital epidemiology 
service.
An advantage of this methodology is that it is fea­
sibly applied to data from relatively small numbers of pa­
tients. We demonstrated its use by analyzing results of a 
prospective study in which all unique clinical isolates of 
gram-negative rods and S. aureus were ribotyped. The 
model-derived rates of transmission for different organ­
isms across intensive care units varied substantially, with 
S. aureus in the surgical intensive care unit ranked the 
highest. However, the point estimates exhibited wide con­
fidence limits. This imprecision is not unexpected, given 
the relatively small numbers of patients on each ward, 
the even smaller numbers of infections, and the resulting 
stochastic variability in the model. Other hospital trans­
mission models have likewise shown a high degree of sto­
chastic variation.17 It is encouraging that the precision of 
these estimates can be markedly improved by selecting 
one or two patients per week on the ward for surveillance 
cultures.
Several other authors have estimated nosocomial 
transmission rates by fitting data to mathematical mod­
els.1821 Most of these previous studies relied on informa­
tion gathered from extensive surveillance culturing.,M0 
Such culturing strategies have not become widespread 
outside of research settings, in part due to the costs in­
volved. In contrast, Cooper and Lipsitch have proposed a 
hidden Markov model approach that can be used with clin­
ical culture data only.21 Their transmission rate estimates
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FIGURE 2. Transmission rate estimates with 95% confidence intervals ver­
sus number of cultures (burn intensive care unit Pseudomonas aeruginosa 
with simulated surveillance cultures).
were associated with tighter confidence intervals than 
those in this article, but they used 40 months of data for 
each estimate as compared with 8 months in this article. 
Thus, it is difficult to directly compare the results.
A  key difference between the model proposed in this 
article and other models of nosocomial infection is that it 
is based on strain diversity, rather than on the numbers of 
clinically infected or colonized individuals. In the model re­
ported here, the dates of detection of clinical infections are 
fixed to occur on the dates that organisms were recovered. 
Conditioning on the actual infection date assumes that fac­
tors that influence clinical infection are independent of the 
underlying transmission dynamics and that different strains 
are equally likely to cause clinical infection. This is an ad­
vantageous assumption to the extent that clinical infection 
rates are sensitive to many sources of variation besides 
transmission, such as underlying illness and medical device 
use. This variation is controlled for by this methodology.
Another key distinction between this model and sev­
eral previously published transmission models is the use 
of discrete event simulation. In this approach, subjects 
are individually traced to allow monitoring of each colo­
nized patient’s strain type. Although deterministic models 
(including those based on differential equations) may be 
more mathematically satisfying as well as more familiar to 
readers, it is not clear how well they model the highly non- 
deterministic transmission patterns seen at the scale of an 
individual hospital unit.17
The transmission rate as presented here is related 
to, but not identical to, the basic transmission parameter 
R0. R0 is defined as the average number of secondary cas­
es of infection, or sometimes colonization, resulting from 
a single primary case in a fully susceptible population.22 
The transmission rate as presented here can be thought 
of as R0 divided by the average post-colonization length 
of stay. Examples of published R0 estimates in intensive 
care settings include 0.14 for P. aeruginosa20 and 0.69 for 
vancomycin-resistant enterococci.19 When length of stay 
is adjusted for, the estimates produced by this model cor­
respond to R0 values ranging from 0 to 2.1.
FIGURE 3. Diagram of the transmission model.
This model includes several simplifying assump­
tions. It assumes a constant admission rate regardless 
of infection status, so that lengths of stay follow an ex­
ponential distribution. It assumes constant transmissi- 
bility and infectivity across strains and across patients, 
and equal prevalence of each community strain. (An 
example of a violation of this last assumption would be 
patients returning to the hospital still colonized from the 
previous visit.) The model also assumes that colonized 
patients have exactly one strain, are as susceptible as 
non-colonized patients to acquiring a new strain, and are 
all equally likely to transmit to new patients (eg, without 
regard to infection status of the transmitter). Assessing 
the significance of this set of limitations would require 
comparing the performance of this model with that of a 
somewhat more complex strain carriage and transmis­
sion model. Finally, it assumes that all patients are ad­
mitted directly to the ward of interest from the commu­
nity, with no transmission between patients on different 
wards. This last assumption in particular is violated to 
some degree on certain hospital units such as intensive 
care units. Assessing the significance of this violation 
will require prospective assessment of colonizing strain 
diversity on admission to different units. All of these 
aspects of the model could in principle be made more 
biologically realistic, but at the expense of adding ad­
ditional parameters, the estimation of which would add 
additional sources of error.23
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This model was not designed to be able to detect 
emergence of new strains, whether the result of selective 
pressure such as antibiotic use or importation of strains 
from other communities. In fact, the model assumes that 
the number and distribution of strains do not change over 
time. One practical impact of this might be the need for pe­
riodic reassessment of community strain diversity to reca­
librate the model.
The model is only moderately sensitive to the num­
ber of distinguishable strains in the community, which in 
turn is a function of the discriminatory power of the geno- 
typing method. Thus, methods with more or less discrimi­
natory power than the RiboPrinter would be expected to 
produce somewhat narrower or wider confidence inter­
vals, respectively. The fact that the model, or for that mat­
ter the Simpson’s index, is not more sensitive to the num­
ber of community strains may be counterintuitive. This is 
perhaps best explained by the fact that the probability of 
two infections being of the same strain in the absence of 
transmission is proportional to the inverse of the number 
of community strains. These inverses are all small rela­
tive to the probabilities of detecting transmission-related 
same-strain infections, at least within the ranges of param­
eters tested. For a few species, one or two ribotypes may 
account for a large proportion of colonization in a com­
munity.24 For such species, this model could give skewed 
results.
Given these sources of structural and parametric 
uncertainty, it is difficult at this point to assess the abso­
lute accuracy of the transmission rate estimates produced 
by this model. For example, it currently would be prema­
ture to use these estimates to draw conclusions about the 
relative transmission rates of S. aureus versus P. aeruginosa 
in different hospital locations. The need for accuracy de­
pends on the application under consideration. For quality 
improvement, the key issue is the ability to detect changes 
over time, and so precision is more important than abso­
lute accuracy. For comparison between wards or between 
institutions, the key issues are precision and avoidance of 
differential biases. Further validation of the model and as­
sessment of its accuracy will require a prospective clinical 
study with serial culturing as a gold standard to determine 
transmission rates.
These results suggest that bacterial strain typing 
can be combined with a mathematical model to estimate 
transmission rates in healthcare settings. They also sug­
gest that analysis based on strain typed clinical cultures 
alone is probably insufficient to produce precise enough 
transmission rate estimates for use in routine infection 
control. One obvious way to extend the model, as shown 
in Figure 2, is to add a modest number of surveillance 
cultures. We are currently working on a more general 
statistical model using Markov chain Monte Carlo tech­
niques.25-26 This will allow incorporation of additional 
data, such as time from admission to infection and re­
sults of repeat surveillance cultures on selected patients, 
to improve precision and control for variable distribu­
tions of strains at admission.
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A P P E N D IX
D E S C R IP T IO N  O F  T H E  M O D E L  (F IG . 3) 
V ariables
S = number of unique strains of the species of inter­
est in the community. All are assumed to exist at an equal 
frequency.
N = number of hospital beds. All beds are assumed to 
be filled at all times, so that when a patient is discharged, a 
new one is simultaneously admitted.
p = admission rate.
p = probability that a randomly chosen patient is colo­
nized at the time of admission. Thus, the probability that 
a randomly chosen patient is not colonized at admission 
equals 1 - p, and the probability that a randomly chosen 
patient is colonized at admission with a specified strain 
equals p/S.
p = transmission rate = average number of transmis­
sion events per colonized patient per day.
Model Events
Admission/Discharge: An admission/discharge event 
consists of randomly selecting a bed, deleting the strain 
identifier associated with that bed (if any), and then assign­
ing a new strain identifier to that bed with probability p. Ad­
mission/discharge events take place randomly throughout 
each simulated model day according to a Poisson process 
with parameter p.
Transmission: For each transmission event, one 
patient is randomly selected from among all admitted, 
currently colonized patients to be the transmitting patient. 
A  different patient is then selected from among all cur­
rently admitted patients to be the receiving patient. The 
receiving patient’s colonization status is then set to true 
(regardless of whether this patient had previously been 
colonized), and the strain number is set to the strain num­
ber of the transmitting patient. Transmission events take 
place randomly throughout each simulated model day ac­
cording to a Poisson process with parameter p.
Culture: Culture dates are set according to the dates 
in the observed data set. Thus, if the observation data in­
cluded cultures on each of the days 1, 2, and 10, then the 
model would simulate a culture on days 1, 2, and 10 of each 
simulation. Patients are assumed to have a maximum of one 
culture per hospital stay. Each simulated culture consists of 
randomly choosing one patient from among all currently 
colonized patients who had not previously had a culture and 
recording the strain number carried by that patient.
